Word

BIONTECH

Status

Registered

Status Code

700

Status Date

Tuesday, June 2, 2020

Serial Number

79263465

Registration Number

6066335

Registration Date

Tuesday, June 2, 2020

Mark Type

5000

Filing Date

Friday, April 5, 2019

Published for Opposition

Tuesday, March 17, 2020

Trademark Owner History

BioNTech SE - Original Registrant

Classifications

5 Pharmaceutical and veterinary preparations, namely, preparations for the prevention and treatment of proliferative diseases, cancers, infectious diseases, autoimmune diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; vaccines, namely, DNA-based and RNA-based vaccines, adjuvant preparations for use with vaccines, nucleic acids sequences, proteins, and chemical reagents for medical and veterinary purposes, protein conjugates, peptides featuring antibodies and tumour markers; cell-based immunotherapeutic treatment by way of genetically modified cells, medicated serums for the treatment of proliferating diseases, cancers, infectious diseases, and autoimmune diseases, attenuated viruses and particles similar to viruses, namely, encapsulated nucleic acids; diagnostic reagents and diagnostic preparations for medical purposes

1 Chemicals used in industry and science, in particular for use in biotechnology, pharmaceutics, medicine and veterinary medicine

44 Medical services; providing medical care services and consultation related thereto; urgent medical care centers; pharmaceutical and medical consultancy; providing healthcare information and advisory services in the healthcare field; medical consultation services featuring preparation of reports relating to medical and pharmaceutical services; medical and pharmaceutical consultation; all the aforesaid services other than in the field of bione therapy or other types of therapy combined with bione therapy

42 Scientific research and development in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, in particular research and development in the field of medical and veterinary diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; scientific research and development of diagnostic methods and test processes; scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; scientific consultancy services in the field of research and development of therapies and medical preparations; providing of scientific expertise in the nature of scientific study and research in the field of medicine; scientific research and development for medical and veterinary purposes; conducting and evaluating medical and pharmaceutical studies, namely, testing, analysis and evaluation of goods/services of others to determine conformity with certification standards

The mark consists of the stylized wording "BIONTECH".
Color is not claimed as a feature of the mark.

Trademark Events

Apr 15, 2022

New Representative At Ib Received

Oct 18, 2020

Final Decision Transaction Processed By Ib

Sep 28, 2020

Final Disposition Notice Sent To Ib

Sep 28, 2020

Final Disposition Processed

Sep 2, 2020

Final Disposition Notice Created, To Be Sent To Ib

Jun 2, 2020

Registered-Principal Register

Mar 17, 2020

Official Gazette Publication Confirmation E-Mailed

Mar 17, 2020

Published For Opposition

Mar 13, 2020

Notification Processed By Ib

Feb 26, 2020

Notification Of Possible Opposition Sent To Ib

Feb 26, 2020

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Feb 26, 2020

Notification Of Notice Of Publication E-Mailed

Feb 13, 2020

Change Of Name/Address Rec'd From Ib

Feb 11, 2020

Assigned To Lie

Feb 7, 2020

Approved For Pub - Principal Register

Feb 6, 2020

Teas/Email Correspondence Entered

Feb 5, 2020

Correspondence Received In Law Office

Feb 5, 2020

Teas Response To Office Action Received

Oct 24, 2019

Change Of Name/Address Rec'd From Ib

Aug 30, 2019

Refusal Processed By Ib

Aug 15, 2019

Non-Final Action Mailed - Refusal Sent To Ib

Aug 15, 2019

Refusal Processed By Mpu

Jul 26, 2019

Application Filing Receipt Mailed

Jul 23, 2019

Non-Final Action (Ib Refusal) Prepared For Review

Jul 22, 2019

Non-Final Action Written

Jul 22, 2019

Assigned To Examiner

Jul 22, 2019

New Application Office Supplied Data Entered In Tram

Jul 18, 2019

Sn Assigned For Sect 66a Appl From Ib